Search CROs

• Biomarker Assays
• Biostatistics & Statistical Programming
• Clinical Operations

Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation. The organization delivers Phase I–IV…

• Biostatistics & Statistical Programming
• Central Laboratory Services
• Clinical Imaging Core Lab

Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

Labcorp Early Development Services is part of Labcorp, a global life sciences and healthcare company offering integrated drug development and diagnostic services. The organization supports nonclinical research, central laboratory services, early phase development, regulatory…

• Bioanalysis
• Biomarker Assays
• Biostatistics & Statistical Programming

ICON is a world-leading clinical research organization providing outsourced services across the full clinical trial lifecycle, from early phase through commercialization, to pharmaceutical, biotechnology, and medical device companies.

• Bioanalysis
• Bioinformatics & Data Science
• Biomarker Assays

IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.

• Cardiovascular & Metabolic Specialty Services
• Clinical Operations
• Phase I Clinical Trials

Global CRO with 25+ years of experience and world-renowned renal expertise, offering end-to-end clinical trial services across renal, oncology, cardiovascular, and early-phase research with operations spanning 70+ countries.

• Cardiovascular & Metabolic Specialty Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.

• Bioanalysis
• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services

Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.

• Biostatistics & Statistical Programming
• Cardiovascular & Metabolic Specialty Services
• Clinical Operations

Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.

• Cardiovascular & Metabolic Specialty Services
• Central Laboratory Services
• Clinical Imaging Core Lab

Specialized cardiovascular CRO offering full-spectrum clinical development from protocol design through regulatory submission, with deep cardiology expertise and core laboratory services across all development phases.

• Immunology & Inflammation Services
• In Vitro Pharmacology
• In Vivo Efficacy Models

Cyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.